Evidence map›Paper›PMID 29020149›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel.

Valeria Fabre, Sara E Cosgrove

Abstract readEditorialComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Valeria FabreDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Sara E CosgroveDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
AHRQ HHS HHSP233201500020INCEZID CDC HHS U54 CK000447NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeDisease OutbreaksDrug Resistance, MicrobialEnterobacteriaceae InfectionsHumansInfection ControlIsraelantibiotic resistanceantibiotic stewardshipcarbapenem-resistant Enterobacteriaceaeinfection prevention

Identifiers

PMID29020149
PMCPMC5848331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.